Riskpilot← Back to searchSign inGet full accessSanjus Medical AB
ABActiveOrg 5569290132Södra Vägen 2General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 326K
-62% vs 2023
EBITDA margin
-46.9%
-139% vs 2023
Equity ratio
96.1%
Financial strength
Net profit 2024
SEK -257K
-151% vs 2023
| Revenue | SEK 326K | -62% |
| EBITDA | SEK -153K | -139% |
| Net profit | SEK -257K | -151% |
| Total assets | SEK 2M | -21% |
| Equity | SEK 1,9M | -20% |
| Employees | 0 | — |
Legal name
Sanjus Medical AB
Org number
5569290132
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 april 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva praktik- och konsultverksamhet inom hälso- och sjukvård, utbildningsverksamhet inom hälso- och sjukvård, handel med värdepapper och därmed förenlig verksamhet.
Address
Södra Vägen 2
Email
ramunddal@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 332 | 224 | 625 | 862 | 326 |
| Staff expenses | — | — | — | — | −155 |
| EBITDA | 138 | 26 | 416 | 391 | −153 |
| Depreciation & amort. | −41 | −0 | −0 | −0 | — |
| EBIT | 97 | 26 | 416 | 391 | −153 |
| Net financials | — | −228 | −1 197 | 198 | −104 |
| Profit before tax | 745 | 363 | −182 | 590 | −257 |
| Tax | −166 | −102 | −95 | −89 | — |
| Net profit | 579 | 261 | −277 | 501 | −257 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 151 | 2 527 | 2 314 | 2 469 | 1 960 |
| Equity | 2 426 | 2 506 | 2 040 | 2 341 | 1 884 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 274 | 21 | 274 | 128 | 76 |
| Total debt | 274 | 21 | 274 | 128 | 76 |
EBITDA margin
-46.9%
This company
15.8%
Market median
-397% vs market
20202024
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
-13.7%
This company
18.4%
Market median
-174% vs market
20202024
Net profit margin
-78.9%
This company
8.1%
Market median
-1074% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sanjus Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Truls Are Råmunddal | Board of Directors | 0 companies |
| Araz Rawshani | Deputy Board Member | 0 companies |